Global and cell type-specific immunological hallmarks of severe dengue progression
暂无分享,去创建一个
S. Quake | J. Montoya | F. Luciani | F. Zanini | B. Pinsky | Zhiyuan Yao | H. B. Cagirici | S. Einav | M. Sahoo | J. Samir | Olga Lucia Agudelo Rojas | F. Rosso | Yike Xie | Verónica Durán | L. Ghita | L.A. Villar Centeno | A. Sanz | Rosa Margarita Gélvez | Nathalia Bueno | Makeda L. Robinson | María Isabel Estupiñán Cárdenas | Elsa Marina Rojas Garrido | Veronica Duran | Ilham Osman | Halise Busra Cagirici
[1] J. Montoya,et al. Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics , 2022, bioRxiv.
[2] S. Kabra,et al. Contrasting behavior between the three human monocyte subsets in dengue pathophysiology , 2022, iScience.
[3] Aditya M. Rao,et al. An 8-gene machine learning model improves clinical prediction of severe dengue progression , 2022, Genome Medicine.
[4] J. Modiano,et al. Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells , 2022, Frontiers in Immunology.
[5] S. Sagan,et al. Molecular Determinants of Flavivirus Virion Assembly. , 2021, Trends in biochemical sciences.
[6] Jaime Fern'andez del R'io,et al. Array programming with NumPy , 2020, Nature.
[7] S. Vasudevan,et al. Positive epistasis between viral polymerase and the 3′ untranslated region of its genome reveals the epidemiologic fitness of dengue virus , 2020, Proceedings of the National Academy of Sciences.
[8] Mirjana Efremova,et al. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes , 2020, Nature Protocols.
[9] A. Rothman,et al. Analysis of cell-associated DENV RNA by oligo(dT) primed 5’ capture scRNAseq , 2020, Scientific Reports.
[10] I. Rodenhuis-Zybert,et al. Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection , 2019, Front. Immunol..
[11] A. Muntasell,et al. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes , 2019, Front. Immunol..
[12] B. Restrepo,et al. Different phenotypes of non‐classical monocytes associated with systemic inflammation, endothelial alteration and hepatic compromise in patients with dengue , 2019, Immunology.
[13] Francesco Vallania,et al. A 20-Gene Set Predictive of Progression to Severe Dengue , 2019, Cell reports.
[14] Vincent A. Traag,et al. From Louvain to Leiden: guaranteeing well-connected communities , 2018, Scientific Reports.
[15] A. Khromykh,et al. Subgenomic flaviviral RNAs: What do we know after the first decade of research , 2018, Antiviral research.
[16] K. Weeks,et al. Pervasive tertiary structure in the dengue virus RNA genome , 2018, Proceedings of the National Academy of Sciences.
[17] D. Kaufman,et al. Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells , 2018, bioRxiv.
[18] D. Gubler,et al. Development of standard clinical endpoints for use in dengue interventional trials , 2018, PLoS neglected tropical diseases.
[19] D. Davis,et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells , 2018, The Journal of cell biology.
[20] G. Ogg,et al. Regulatory T‐cells in acute dengue viral infection , 2018, Immunology.
[21] M. Halloran,et al. Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] M. Halloran,et al. Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.
[23] S. Quake,et al. Single-cell transcriptional dynamics of flavivirus infection , 2017, bioRxiv.
[24] A. Rothman,et al. Immune-mediated cytokine storm and its role in severe dengue , 2017, Seminars in Immunopathology.
[25] K. Porter,et al. NK cell degranulation as a marker for measuring antibody-dependent cytotoxicity in neutralizing and non-neutralizing human sera from dengue patients. , 2017, Journal of immunological methods.
[26] J. Taubenberger,et al. IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity , 2017, Science.
[27] Julio Saez-Rodriguez,et al. OmniPath: guidelines and gateway for literature-curated signaling pathway resources , 2016, Nature Methods.
[28] S. A. de Oliveira,et al. Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever. , 2015, Acta tropica.
[29] P. V. Lakshmana Rao,et al. Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection , 2015, Archives of Virology.
[30] S. Halstead,et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. , 2014, Human pathology.
[31] G. Ogg,et al. Suppression of Virus Specific Immune Responses by IL-10 in Acute Dengue Infection , 2013, PLoS neglected tropical diseases.
[32] E. Harris,et al. Comparison of the FDA-Approved CDC DENV-1-4 Real-Time Reverse Transcription-PCR with a Laboratory-Developed Assay for Dengue Virus Detection and Serotyping , 2013, Journal of Clinical Microbiology.
[33] J. Razzak,et al. A comparison of WHO guidelines issued in 1997 and 2009 for dengue fever - single centre experience. , 2013, JPMA. The Journal of the Pakistan Medical Association.
[34] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[35] A. Rudensky,et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.
[36] O. Horstick,et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries , 2011, BMC infectious diseases.
[37] D. Jans,et al. Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-alpha to activate nuclear factor kappaB and reduced sphingosine kinase-1 activity. , 2011, The Journal of general virology.
[38] B. Ryffel,et al. Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice , 2010, PloS one.
[39] E. Harris,et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. , 2009, The American journal of tropical medicine and hygiene.
[40] Kevin R Porter,et al. Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. , 2009, Virology.
[41] Mauricio L. Barreto,et al. Recent Shift in Age Pattern of Dengue Hemorrhagic Fever, Brazil , 2008, Emerging infectious diseases.
[42] E. Harris,et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. , 2008, Virology.
[43] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[44] J. Schlesinger,et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells , 2008, Journal of medical virology.
[45] E. Harris,et al. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. , 2007, The Journal of infectious diseases.
[46] N. M. Dung,et al. Increased frequencies of CD4+CD25high regulatory T cells in acute dengue infection , 2007, The Journal of experimental medicine.
[47] Trai-Ming Yeh,et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.
[48] E. Harris,et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. , 2005, The American journal of tropical medicine and hygiene.
[49] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .
[50] A. Nisalak,et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. , 2002, The Journal of infectious diseases.
[51] S. Halstead,et al. Effect of age on outcome of secondary dengue 2 infections. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.